High C-Reactive Protein/Low Serum Albumin: A Hidden Villain in Cardiovascular Disease

Abstract

Keywords

CRP Serum albumin coronary artery disease cardiovascular diseases myocardial infarction percutaneous coronary intervention

Get full access to this article

View all access options for this article.

References

Yang

Zheng

, et al. The Association Between High-Sensitivity C-Reactive Protein/Albumin Ratio and Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention. Angiology 2022;73:818-826.

Manolis

Melita

Mikhailidis

Manolis

. Low serum albumin: A neglected predictor in patients with cardiovascular disease. Eur J Intern Med 2022;102:24-39.

Wada

Dohi

Miyauchi

, et al. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention. Circ J 2017;81:1293-300.

Huang

Chen

, et al. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study. BMC Cardiovasc Disord 2021;21:613.

Guedeney

Claessen

Kalkman

, et al. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol 2019;73:2401-9.

Liu

Tang

Cheng

, et al. C-reactive protein-to-serum albumin ratio as a novel predictor of long-term outcomes in coronary artery disease patients who have undergone percutaneous coronary intervention: analysis of a real-world retrospective cohort study. Coron Artery Dis 2021;32:191-196.

Ronit

Kirkegaard-Klitbo

Dohlmann

, et al. Plasma albumin and incident cardiovascular disease: results from the cgps and an updated meta-analysis. Arterioscler Thromb Vasc Biol 2020;40:473-482.

Kalkan

Cagan Efe

Karagöz

, et al. A new predictor of mortality in st-elevation myocardial infarction: the uric acid albumin ratio. Angiology 2022;73:461-469.

Akirov

Masri-Iraqi

Atamna

Shimon

. Low albumin levels are associated with mortality risk in hospitalized patients. Am J Med 2017;130:1465.e11-1465.e19.

10.

Turkyilmaz

Ozkalayci

Birdal

, et al. Serum Albumin to Creatinine Ratio and Short-Term Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction. Angiology 2022;73:809-817.

11.

Manolis

Melita

. Atherosclerosis: an Athero-Thrombo-Inflammatory Disease. Hosp Chronicles 2012;7: 195-201.

12.

Duman

Çinier

Bakırcı

, et al. Relationship Between C-Reactive Protein to Albumin Ratio and Thrombus Burden in Patients With Acute Coronary Syndrome. Clin Appl Thromb Hemost 2019;25:1076029618824418.

13.

Ridker

Everett

Thuren

, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med 2017;377:1119-31.

14.

Kaura

Hartley

Panoulas

, et al. Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: A cohort study. PLoS Med 2022;19:e1003911.

15.

Andreotti

Maggioni

Campeggi

Iervolino

Scambia

Massetti

. Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine. Eur Heart J Suppl 2021;23:E13-E18.

16.

Sun

Dubé

Hennessy

, et al. Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies. Int J Cardiol 2022;363:20-2.

17.

Ridker

Everett

Pradhan

, et al. Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med 2019;380:752-62.